RAPT Therapeutics Inc. (RAPT)

NASDAQ: RAPT · Real-Time Price · USD

0.96

0.04 (4.90%)

At close: May 02, 2025, 3:59 PM

0.95

-1.53%

After-hours: May 02, 2025, 04:09 PM EDT

RAPT Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	169.74M	47.48M	38.95M	24.03M	24.92M	77.38M	63.8M	47.52M
Short-Term Investments	61.32M	111.38M	210.12M	165.63M	86.59M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	598K	605K
Other Long-Term Assets	389K	3.87M	4.04M	2.92M	389K	389K	-209K	-369K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.18M	2.92M	3.63M	3.32M	4.09M	3.12M	n/a	n/a
Total Current Assets	235.24M	161.78M	252.69M	192.97M	115.6M	80.51M	65.06M	48.24M
Property-Plant & Equipment	4.7M	7.68M	9.48M	2.74M	2.98M	3.71M	4.16M	1.91M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.09M	11.55M	13.52M	5.66M	3.37M	4.1M	4.55M	2.15M
Total Assets	240.32M	173.33M	266.21M	198.64M	118.97M	84.6M	69.61M	50.39M
Account Payables	1.27M	5.18M	3.37M	2M	2.38M	1.14M	1.77M	1.11M
Deferred Revenue	n/a	n/a	n/a	1.02M	4.1M	4M	n/a	n/a
Short-Term Debt	2.42M	n/a	2.17M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	9.65M	7.91M	2.48M	2.93M	2.3M	2.33M	586K	650K
Total Current Liabilities	48.35M	21.84M	14.22M	9.6M	11.74M	9.26M	4.64M	3.25M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	108.64M
Other Long-Term Liabilities	n/a	n/a	n/a	2.15M	2.19M	2.23M	969K	905K
Total Long-Term Liabilities	2.07M	4.46M	6.82M	2.66M	3.05M	2.23M	969K	109.55M
Total Liabilities	50.42M	26.29M	21.04M	12.26M	14.79M	11.48M	5.61M	112.8M
Total Debt	4.49M	6.91M	8.99M	n/a	n/a	n/a	161.11M	108.64M
Common Stock	13K	3K	3K	3K	2K	2K	2K	1K
Retained Earnings	-614.55M	-484.68M	-367.88M	-284.05M	-214.84M	-161.95M	-118.95M	-82.81M
Comprehensive Income	50K	103K	-26K	-206K	-177K	20K	-4K	-3.77M
Shareholders Equity	189.9M	147.03M	245.17M	186.38M	104.18M	73.12M	64M	-62.41M
Total Investments	61.32M	111.38M	210.12M	165.63M	86.59M	n/a	598K	605K